Patents by Inventor Philip Wendler

Philip Wendler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6846625
    Abstract: The invention comprises methods useful within a larger process for identifying compounds and/or designing further compounds with activity to produce a desired phenotype (for example, growth inhibition) in cells whose target cell component is the subject of certain studies to identify such compounds. The invention employs constructed cells comprising a regulable gene encoding a biomolecule which modulates (inhibits or activates) in vivo the function of a target component of the cell which can be an enzyme for example. The process incorporates methods for identifying biomolecules that bind to a chosen target cell component in vitro, methods for identifying biomolecules that also bind to the chosen target and modulate its function intracellularly, causing a phenotypic effect.
    Type: Grant
    Filed: January 8, 1999
    Date of Patent: January 25, 2005
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Francis P. Tally, Jianshi Tao, Philip A. Wendler, Gene Connelly, Paul L. Gallant
  • Publication number: 20040033481
    Abstract: The invention comprises methods useful within a larger process for identifying compounds and/or designing further compounds with activity to produce a desired phenotype (for example, growth inhibition) in cells whose target cell component is the subject of certain studies to identify such compounds. The invention employs constructed cells comprising a regulable gene encoding a biomolecule which modulates (inhibits or activates) in vivo the function of a target component of the cell which can be an enzyme, for example, methionyl-tRNA synthetase of Staphylococcus aureus. The process incorporates methods for identifying biomolecules that bind to a chosen target cell component in vitro, methods for identifying biomolecules that also bind to the chosen target and modulate its function intracellularly, causing a phenotypic effect.
    Type: Application
    Filed: October 22, 2002
    Publication date: February 19, 2004
    Applicant: Cubist Pharmaceuticals, Inc.
    Inventors: Francis P. Tally, Jianshi Tao, Philip A. Wendler, Gene Connelly, Paul L. Gallant
  • Patent number: 6475726
    Abstract: The invention comprises methods useful within a larger process for identifying compounds and/or designing further compounds with activity to produce a desired phenotype (for example, growth inhibition) in cells whose target cell component is the subject of certain studies to identify such compounds. The invention employs constructed cells comprising a regulable gene encoding a biomolecule which modulates (inhibits or activates) in vivo the function of a target component of the cell which can be an enzyme, for example, methionyl-tRNA synthetase of Staphylococcus aureus. The process incorporates methods for identifying biomolecules that bind to a chosen target cell component in vitro, methods for identifying biomolecules that also bind to the chosen target and modulate its function intracellularly, causing a phenotypic effect.
    Type: Grant
    Filed: June 25, 1999
    Date of Patent: November 5, 2002
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Francis P. Tally, Jianshi Tao, Philip A. Wendler, Gene Connelly, Paul L. Gallant, Xiaoyu Shen, Jiansu Zhang
  • Patent number: 6153645
    Abstract: Methods for treating infection and related compositions, compounds of formula I as defined in the application and methods for preparing same, are provided. In general, the compounds inhibit transfer ribonucleic acid (tRNA) synthetase and are useful as antimicrobial agents.
    Type: Grant
    Filed: September 10, 1999
    Date of Patent: November 28, 2000
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: John Finn, Xiang Yang Yu, Zhongguo Wang, Jason Hill, Dennis Keith, Paul Gallant, Philip Wendler
  • Patent number: 5998197
    Abstract: Ascospores of wood-penetrating, pitch-grading fungi of the class of Ascomycotina and Deuteromycotina, eg. Ophiostromas, may be screened to provide fungi combining the properties of good growth on non-sterile wood substrates and minimized or even enhanced brightness effects for use in pitch reduction of wood substrates, eg. logs and wood chips. A new and improved method of isolating such ascospores involving effective suspension in an oil consumable by the fungus, eg. a vegetable oil, and then treatment of the oil with a dispersing agent is also disclosed.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 7, 1999
    Assignee: Clariant Finance (BVI) Limited
    Inventors: Roberta L. Farrell, Yitzhak Hadar, Philip A. Wendler, Wendy Zimmerman
  • Patent number: 5853537
    Abstract: Wood-penetrating fungi of the classes Ascomycotina and Deuteromycotina may be used very effectively to degrade pitch in wood forms used in the making of cellulosic products. Such fungi include but are not limited to the blue stain fungi. The process of Ascospore selection may be used to provide fungi which exhibit good growth on wood substrate while having little or no effects on substrate brightness, or even a positive effect on brightness. The treatment positively influences strength properties of ultimate products such as paper. In one embodiment the pulpwood or pulp is treated with a pitch degrading fungus of the genus Ophiostoma.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: December 29, 1998
    Assignee: Clariant Finance (BVI) Limited
    Inventors: Robert A. Blanchette, Roberta L. Farrell, Yitzhak Hadar, Johnnie E. Merritt, II, Robert A. Snyder, Philip A. Wendler, Wendy Zimmerman
  • Patent number: 5609724
    Abstract: Ascospores of wood-penetrating, pitch-grading fungi of the class of Ascomycotina and Deuteromycotina, eg. Ophiostromas, may be screened to provide fungi combining the properties of good growth on non-sterile wood substrates and minimized or even enhanced brightness effects for use in pitch reduction of wood substrates, eg. logs and wood chips. A new and improved method of isolating such ascospores involving effective suspension in an oil consumable by the fungus, eg. a vegetable oil, and then treatment of the oil with a dispersing agent is also disclosed.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: March 11, 1997
    Assignee: Sandoz Ltd
    Inventors: Roberta L. Farrell, Yitzhak Hadar, Philip A. Wendler, Wendy Zimmerman
  • Patent number: 5476789
    Abstract: Ascospores of wood-penetrating, pitch-grading fungi of the class of Ascomycotina and Deuteromycotina, e.g. Ophiostromas, may be screened to provide fungi combining the properties of good growth on non-sterile wood substrates and minimized or even enhanced brightness effects for use in pitch reduction of wood substrates, e.g. logs and wood chips. A new and improved method of isolating such ascospores involving effective suspension in an oil consumable by the fungus, e.g. a vegetable oil, and then treatment of the oil with a dispersing agent is also disclosed.
    Type: Grant
    Filed: October 1, 1993
    Date of Patent: December 19, 1995
    Assignee: Sandoz Ltd.
    Inventors: Roberta L. Farrell, Yitzhak Hadar, Philip A. Wendler, Wendy Zimmerman